Overview

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

Status:
Withdrawn
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate the efficacy of type-5 phosphodiesterase inhibitors (sildenafil) in primary and secondary pulmonary hypertension
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Phosphodiesterase Inhibitors
Sildenafil Citrate